Objective: Renal allograft recipients are at higher risk of developing tuberculosis (TB) as compared to the general population. The infection also carries with it a significant morbidity and mortality. However, data is limited regarding its incidence and risk factor analysis in our setting. This study determined the incidence, characteristics and risk factors of post-transplant TB in National Kidney and Transplant Institute (NKTI).

Methods: This is a retrospective study involving chart review of 1,621 renal allograft recipients from 2003-2009. We recorded demographic information, transplant characteristics, median time to diagnosis of TB and forms of TB.

Results: The incidence of TB in renal allograft recipients is 2.6%. Median time to diagnosis of TB after transplant is 21 months (one to 105 months). Risk factors identified in this study were previous history of TB (OR 4.15, 95% CI 1.4-12.2), one episode of rejection (OR 2.33, 95% CI 1.2-4.6) and subsequent use of methylprednisolone as anti-rejection therapy (OR 2.36, 95% CI 1.3-4.4). Patients given a tacrolimus based regimen (OR 0.5, 95% CI 0.24-1.03) and those without episode of rejection (OR 0.43, 95% CI 0.22-0.84) had less tendency to develop post-transplant TB. There were no sufficient evidence to prove association between onset of TB and use of isoniazid prophylaxis, use of induction immunosuppression and type of immunosuppression. Eighty one percent (81%) had pulmonary and 19% had extrapulmonary forms of TB.

Conclusion: Incidence of TB among renal allograft recipients is lower as compared to other high TB burden countries but is still higher as compared to the general Filipino population. The study identified multiple risk factors for post-transplant TB. Prevention of these diseases and identification of patients at risk are as important as early diagnosis and treatment of post-transplant TB.

Keywords: renal transplant, TB, risk factor s , immunosuppression, rejection  

1. Task Force for Tuberculosis, Philippine Practice Guideline in Infectious Diseases. The Philippine Clinical Practice Guidelines on the Diagnosis, Treatment and Control of Pulmonary Tuberculosis Vol 1 No. 3 Quezon City Philippines: PPGG-IDS Philippine Society of Microbiology and Infectious Diseases and Philippine College of Chest Physicians, 2006.
2. Global Tuberculosis Control: Surveillance, planning, financing: WHO Report 2007. Geneva: World Health Organization (WHO/HTM/TB/2011.16); 2011
3. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. American Journal of Transplantation 2009; 9(Suppl 3): S1–S157.
4. Naqvi R, Naqvi A, Anktar S, et al. Use of isoniazid chemoprophylaxis in renal transplant patients. Nephrol Dial Transplant (2010) 25: 634–637.
5. Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-215.
6. Hall CM, Wilcox PA, Swanepoel CR, Kahn D, Van Zyl Smit R. Mycobacterial infection in renal transplant recipients. Chest 1994; 106: 435-9.
7. Celestial A, Padilla B, Mendoza M, de Luna M. Mycobacterial infections in Renal Allograft Recipients: A Single Center Experience with 52 patients. NKTI Proceedings 2001:
8. Chen CH, Lian JD, Cheng CH et al. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transpl Infect Dis. 2006 Sep; 8(3): 148-56
9. Mendoza MT, Liquete RR, Ona ET, Alano FA. Infections in Renal Allograft Recipients: A Review of the Philippine Experience. Int J Infect Dis 1997; 1:222-225.
10. Rungruanghiranya S, Ekpanyaskul C, Jirasiritum S, Nilthong C, Pipatpanawong K, Mavichak V. Tuberculosis in Thai Renal Transplant Recipients: A 15-year Experience. Transplantation Proceedings 2008; 40, 2376-2379.
11. Yildiz A, Sever MS, Turkmen A, et al. Tuberculosis after renal transplantation: experience of one Turkish centre. Nephrol Dial Transplant (1998) 13: 1872–1875
12. Bumbacea D, Arend SM, Eyuboglu F, et al. The risk of tuberculosis in transplant candidates and recipients: A TBNETconsensus statement. ERJ Express. 2012
13. Basiri A, Hosseini-Moghaddam SM, Simforrosh N, et al. The risk factors and laboratory diagnostics for postrenal transplant tuberculosis: A case-control, county-wide study on definitive cases. Transpl Infect Dis. 2008; 10: 231-235.
14. John GT, Shankar V, Abraham AM, Mukundan U, Punnakuzhathil P and Jacob CK. Risk factors for post-transplant tuberculosis. Kidney International, Vol. 60 (2001), pp. 1148–1153
15. Ou SM, Lui CJ, Teng CJ et al. Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation:a nationwide population-based study in Taiwan. Transpl Infect Dis 2012: 0: 1–8
16. Peleg AY, Husain S, Kwak EJ. Opportunistic Infections in 547 Organ Transplant Recipients Receiving Alemtuzumab, a Humanized Monoclonal CD-52 Antibody. Clinical Infectious Diseases 2007; 44: 204-12.
17. Currie AC, Knight, Morris PJ. Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis. Transplantation 2010; 90(7): 695-704.
18. Ersan S, Celik A, Atila K, Sifil AA et al. Tuberculosis in Renal Transplant Recipients. Renal Failure 2011; 33(8): 753-757.
19. Guida JP, Bignotto R, Urbini-Santos C, et al. Tuberculosis in renal transplant recipients: a Brazilian center registry. Transplant Proc. 2009 Apr; 41 (3): 883-4.
20. KT Manual Core Group. Manual of Kidney Transplantation. National Kidney and Transplant Institute. 2007.
21. Munoz P, Rodriguez C, Bouza E et al. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40: 581.
22. Ghafari A, Makhdoomi K, Ahmadoor P et al. Tuberculosis in Iranian Kidney Transplant Recipients: A Single-Center Experience. Transplantation Proceedings 2007: 39, 1008- 1011
23. Singh N and Patersn D. Mycobacterium tuberculosis Infection in Solid-Organ Transplant Recipients: Impact and Implications for Management. Clinical Infectious Diseases 1998; 27: 1266-77.
24. Aguado JM, Torre-Cisneros J, Fortun J, Benito N, Meije Y, Dobals A, Munoz P. Tuberculosis in Solid-Organ Transplant Recipients: Concensus Statement of the Group for the Study of
25. Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clinical Infectious Diseases 2009; 48: 1276- 84.
26. World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision.
27. Lazo P. Mycobacterial Infections among renal allograft recipients. Phil J Nephrol 1988; III: 380-386.